In an attempt to identify susceptibility loci for bipolar affective disorder, we are currently conducting a systematic genome screen with highly polymorphic microsatellite markers at an average marker spacing of 10 cM in a series of 75 families, comprising 66 families from Germany, eight families from Israel, and one family from Italy. The families were ascertained through index cases with bipolar affective disorder. The distribution of diagnoses is as follows: 126 individuals with bipolar I disorder, 40 with bipolar II disorder, 14 with schizoaffective disorder of the bipolar type, 40 individuals with recurrent unipolar depression, 51 with a minor psychiatric diagnosis, and two individuals with a diagnosis of schizophrenia. One hundred and seventy-one individuals are unaffected. Here, we present results from chromosome 10. Linkage analyses using a total of 33 microsatellite markers with parametric and non-parametric methods provided evidence for linkage at chromosomal region 10q25-q26. The highest two-point LOD score (2.86, = 0.05) was obtained for D10S217 using a dominant genetic model and a broad definition of affection status. The GENEHUNTER program localized the putative susceptibility locus within a ca 15-cM interval between markers D10S1483 and D10S217 with a maximum NPL(all) score of 3.12 (P = 0.0013). Positive linkage findings that have been reported by two independent studies further support the hypothesis of a susceptibility gene for bipolar affective disorder on 10q25-q26. Molecular Psychiatry (2001) 6, 342-349.
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Bipolar affective disorder (BPAD), also known as manic depressive illness, is characterized by severe aberrant mood swings in alternating periods of mania and depression. The disorder is common with a lifetime prevalence of about 1% in all human populations and results in high costs in terms of morbidity as well as mortality. BPAD is substantially responsive to drug treatment, but episodes tend to recur throughout life. Although the etiology and pathophysiology is widely unknown, family, twin and adoption studies argue for a strong genetic determination of the disease. 1 Theories concerning the possible involvement of multiple genes of small effect and/or the occurrence of major allelic effects in epistasis have been advanced. In order to identify genes predisposing to BPAD, in the absence of substantial molecular pathophysiological knowledge, linkage analysis is one of the best available methods. Early linkage studies were conducted in large families and were based on the implausible assumption that a single major gene was responsible for the disorder: loci for BPAD on the X chromosome 2-4 and on chromosome 11p15 5 were reported and attracted considerable attention, but have not withstood molecular studies in independent samples [6] [7] [8] as well as updated and extended analyses by the original groups. 9, 10 The reason for these inconclusive results were, for the most part, problems concerning diagnosis, ascertainment of pedigrees, statistical analysis, and lack of availability of dense genetic linkage maps of highly polymorphic markers.
Since then, advances in diagnostic procedures, choice of families (smaller families, particularly nuclear families with affected sib pairs), statistical methods for linkage analysis, and molecular genetic techniques have provided efficient tools for the investigation of complex genetic traits. Applying these tools, several research groups worldwide are performing linkage studies in BPAD, and promising findings are beginning to emerge. Chromosomal regions of interest include 4p16, [11] [12] [13] 4q35, 14 10p, 15 12q23-q24, [16] [17] [18] [19] 13q32, 13 18 pericentromeric, [20] [21] [22] [23] 18q21-q23, 21, 22, [24] [25] [26] [27] 21q22, [28] [29] [30] and 22q. 31 Some of these regions have been reported in at least two independent studies. Independent confirmation of a mapped chromosomal region is considered to be an important criterion for assuming validity of linkage findings for complex genetic traits.
In an attempt to identify susceptibility loci for BPAD as well as to test prior hypotheses we are conducting a systematic genome screen in a series of 75 families with 444 individuals. Here, we report results from chromosome 10 where we genotyped a total of 33 highly informative microsatellite markers. In a first step, we studied 19 markers at an average spacing of 8.9 cM spanning the whole chromosome. Linkage analyses directed us to a 29-cM interval on the long arm of the chromosome which we subsequently followed up using 14 additional markers. Both parametric and non-parametric analyses provide evidence for linkage and suggest that we have identified a susceptibility locus for BPAD in the 10q25-q26 region.
In a first step, we genotyped 19 markers that were evenly distributed over the whole chromosome 10 with an average distance of 8.9 cM. Prior to analysis, two genetic transmission models (dominant and recessive), and two affection status models (broad and narrow) were delineated. In summary, four models were used for linkage analysis. Results of the two-point LOD score analysis are given in Table 1 . The best results were obtained with two markers on the long arm of chromosome 10: under a dominant model and a broad affection status model (ASM II), D10S217 gave a LOD score of 2.86 at = 0.05. D10S587, which is located 10.3 cM proximal to D10S217, displayed a LOD score of 1.48 at = 0.15. Under the narrow affection status model (ASM I), both D10S217 and D10S587 gave negative LOD scores. Using this model, only D10S192 which is located more than 30 cM apart from D10S217 showed a LOD score Ͼ1 (1.10 at = 0.20). Application of a recessive genetic model using both definitions of affection status resulted in only one LOD score Ͼ1: D10S597 gave 1.06 at = 0.20 with ASM I.
The region implicated by the positive LOD score results for D10S217 and D10S587 was pursued with the placement of 14 additional markers. This led to an average marker distance of 1.7 cM in a 29-cM region including D10S217 and D10S587. Using a dominant model and ASM II, two of the 'second-stage' markers gave LOD scores Ͼ1 (1.29 at = 0.15 for D10S216 and 1.66 at = 0.1 for D10S1727) and one marker yielded a LOD score Ͼ2 (2.12 at = 0.1 for D10S1757) ( Table  1) . Both D10S216 and D10S1727 are located within a 10-cM interval between D10S217 and D10S587. D10S1757 is placed ca 6 cM proximal from D10S587.
Affected sib pair analyses confirmed the results of the two-point LOD score analyses. Analysis of the 19 'first-stage' markers provided evidence for linkage to markers D10S217 (60.4% mean allele sharing, P = 0.019) and D10S537 (57.6% mean allele sharing, P = 0.045) under ASM II (Table 2 ). After inclusion of the 14 additional markers, an excess of allele sharing was observed at D10S1483 (62.0%, P = 0.0067), D10S1723 and D10S216 were marginally significant.
The results of the two-point LOD score and affected sib pair analyses were supported by non-parametric multipoint LOD score analyses using the all-relativeMolecular Psychiatry pair option of the GENEHUNTER program ( Figure 1 ). For the broad diagnostic model (ASM II), we obtained a non-parametric Z-all score of 3.12 (P = 0.0013) at markers D10S587, D10S1723, and D10S216 pointing to a 15-cM candidate region flanked by markers D10S1483 and D10S217. Information extraction in this region is in the range of 0.82-0.97. Two weaker peaks were seen proximal of this region at markers D10S583 (2.01, P = 0.02) and D10S537 (1.90, P = 0.03). These peaks correspond to Z-all scores of just below 2.0 and hence provide substantially less evidence for a true rather than false positive signal.
Parametric multipoint LOD score analyses with GENEHUNTER did not give positive LOD scores for the genetic and diagnostic models tested (data not shown). The lack of evidence for linkage in the parametric multipoint LOD score analysis may indicate that the genetic model is not sufficiently close to the true mode of inheritance. This notion is supported by the observation that despite dense marker spacing in the linked region no maximum two-point LOD score was obtained at a recombination fraction of zero. It has been shown that the power to detect linkage is highest if the analysis model truly reflects the mode of inheritance at the trait locus linked to the marker. [32] [33] [34] For multimarker analysis a misspecified model may even lead to exclusion of linkage for the disease locus. 35, 36 Heterogeneity analysis with the HOMOG program 37 did not provide statistically significant evidence for genetic heterogeneity.
The problems of early linkage studies of BPAD and complex genetic disorders in general have led to major methodological improvements. In the past few years, several groups world-wide have been undertaking linkage studies in a large series of families with BPAD and promising findings are beginning to emerge. The results, however, also make clear what can be expected in the search for susceptibility genes involved in the etiology of genetically complex disorders. The existence of a single major gene that accounts for the majority of BPAD cases seems to be unrealistic. 38 Instead, it is likely that BPAD is caused by the combined action of several susceptibility genes that operate either in epistasis and/or independently. This assumption is supported by the observation that no linkage finding can consistently be replicated in all data sets and that the levels of statistical significance and estimated effects are usually modest. In order to localize these susceptibility genes in the genome, systematic linkage analyses without prior hypotheses are being performed by several groups.
Lander and Kruglyak 39 proposed guidelines for evaluation of results from systematic linkage analyses to avoid a flood of false positive linkage claims: LOD score thresholds of 1.9 and 3.3 correspond to suggestive linkage (statistical evidence that would be expected to occur on average once by chance in a genome screen) and significant linkage (statistical evidence expected to occur 0.05 times in a genome screen), respectively. Following this classification, our results at chromosomal region 10q25-q26 are consist- Note: LOD scores are given for two disease models (broad and narrow) and two genetic models (dominant and recessive). Only positive LOD scores are reported ( max Ͻ 0.5). Genetic distances between markers were taken from the Marshfield sex-averaged linkage map. 63 ent with suggestive linkage. There is an ongoing discussion about the usefulness and impact of LOD score thresholds in genetically complex traits. 40, 41 Although there is agreement on the necessity for such guidelines for communication and evaluation, there are concerns about applying LOD score thresholds too rigorously. So far, and this is especially true for genes with small effects, a true-positive linkage finding cannot be readily distinguished from a false-positive one in the presence of complex genetic mechanisms leading to low statistical power. Therefore, evaluation of linkage findings requires additional criteria beyond LOD score thresholds to reflect the complex situation in multifactorial disease. The most important criterion to assess their validity is considered to be replication in independent studies.
Two regions on chromosome 10 have provided evidence for linkage to neuropsychiatric disorders. For the region around marker D10S1423, located in 10p11-p14, several findings in schizophrenia [42] [43] [44] [45] [46] and one in BPAD 15 have been reported. The second region of interest is located in the telomeric part of the long arm (10q25-q26). In addition to the finding reported here, this particular chromosomal region has provided evidence for linkage to BPAD in two independent studies. 47 , 48 Kelsoe et al 47 investigated 20 families with BPAD and obtained a LOD score of 2.27 for D10S1223 and 1.74 for D10S217. Ewald et al 48 performed a genome screen on two large Danish families with BPAD and reported a LOD score of 2.17 for D10S217. Interestingly, marker D10S217, which gave the highest twopoint LOD score in our own linkage analysis, is also indicated in these independent studies. It is noteworthy that positive linkage findings in schizophrenia have been reported for the very same region. [49] [50] [51] Despite the independent findings in BPAD, these results do not exactly meet the requirements for replication that were proposed by Lander and Kruglyak. These authors suggest that a replicated linkage finding should be based on a significant linkage as prior hypothesis and replication by a suggestive linkage finding. Nevertheless, three independent suggestive linkage findings that point to exactly the same chromosomal region provide a fair degree of confidence in their validity. Further elucidation of the potential role of 10q25-10q26 in BPAD will require application of alternative statistical methods to achieve more statistical power than individual linkage studies. The Genome Search Meta-analysis method (GSMA) recently suggested by Wise et al 52 may be a solution as it allows a systematic integration of linkage data from published results. This method ranks statistical results within an individual scan, and then compares ranks for a genetic region across multiple genome searches. An important feature of this method is that it uses genome-wide linkage results instead of genotype data, as is necessary for a combined re-analysis of linkage data. This will facilitate meta-analyses and may eventually lead to sufficient statistical power to produce definitive results.
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Material and methods
Family ascertainment
A total of 75 families were included in the genetic analyses, comprising 66 families from Germany, eight families from Israel, and one family from Italy.
Standard diagnostic definitions for ascertainment and extension are the following: bipolar I (BPI), schizoaffective, bipolar type (SA/BP), unipolar, recurrent (UPR), unipolar, single episode (UPS) and other minor psychiatric disorders are defined by DSM-III-R criteria; 53 bipolar II (BPII) by Research Diagnostic Criteria (RDC) 54 with the modification that it requires recurrent episodes of depression. The diagnosis of BPII cannot be made in DSM-III-R, but is made in RDC. We additionally specified that depression be recurrent because of concerns about the reliability of hypomania and single-episode major depression. 55 Inclusion criteria for the systematically ascertained BP families were: (1) a proband with BPI and admission to one of the treatment facilities; (2) a secondary Tables 1 and 2 ). Z-all was computed by GENEHUNTER (v 2.0B).
affected sib with either BPI, BPII, SA/BP, or UPR; and (3) availability of both parents or-if only one parent were accessible-availability of at least two more sibs from the sib-ship of the proband.
All individuals were interviewed by an experienced psychiatrist using the Schedule for Affective Disorders and Schizophrenia-Lifetime Version (SADS-L). 56 Best estimate diagnoses were based on the interview, review of all available clinical records, and family history information.
Description of families
The family sample consisted of 444 individuals from 75 families. Seventy of the families were two-generation families, five were three-generation families. None of these families had previously been included in a linkage study with markers from chromosome 10. Results from a subsample have previously been published for markers on chromosomes 12 17 and 18. 22 The mean number of individuals per pedigree was 5.9, and the mean number of affected individuals per pedigree was 2.9. The distribution of diagnoses was as follows: 126 individuals with BPI, 40 individuals with BPII, 14 individuals with SA/BP, 40 individuals with UPR, 51 individuals with a minor psychiatric diagnosis, and two individuals with a diagnosis of schizophrenia. One hundred and seventy-one individuals were unaffected. Sixty-four of the families were nuclear families with at least two affected siblings. Eleven families had two branches with at least two affected siblings in each branch. There were 60 sib-ships with two affected siblings, 17 sib-ships with three affected siblings, five sibships with four affected siblings, two sib-ships with five affected siblings, and two with six affected siblings. Depending on the affection status model (see section 'Linkage analyses'), a maximum number of 83 (under ASM I) or 194 (under ASM II) possible affected sib pairs were included in the analyses.
Except for five families (WUE49, WUE67, WUE78, MAI18, HAA117), there were no families where both parents of the index case had a psychiatric diagnosis. In family WUE49, the father had a diagnosis of BPI, and the mother had a diagnosis of UPR. The father of family WUE78 displayed an adjustment disorder with depressed mood, the mother had UPS. The father of family WUE67 had UPR, the mother was BPI. In family MAI18 the father was diagnosed with UPS, the mother with BPII. Both father and mother of family HAA117 had a personality disorder. According to the affection status models applied in this study, only families WUE49 and WUE67 display bilineal transmission of the disease.
DNA isolation and cell lines
EDTA anticoagulated venous blood samples were collected from 444 individuals who were available for the study. Leukocyte DNA was isolated as described. 57 Whenever possible, leukocytes were isolated and transformed using Epstein-Barr virus in order to establish permanent cell lines.
Genotyping
Genotypic data were collected from 444 individuals. In the first stage, we studied 19 short tandem repeat (STR) markers on chromosome 10 (D10S249, D10S591, D10S189, D10S547, D10S191, D10S548, D10S197, D10S208, D10S220, D10S1652, D10S537, D10S201, D10S583, D10S192, D10S597, D10S190, D10S587, D10S217, D10S212). According to the Marshfield Genetic Map (accessible at http:www.marshmed.org/ genetics/), spacing of the markers ranged from 4.5 cM to 13.5 cM, the average spacing was 8.9 cM. Except D10S1652 which was taken from the Genome Data Base (GDB) Version 5.6, all markers were obtained from the ABI Prism Linkage Mapping Set Version 1.0 (Applied Biosystems, Foster City, CA, USA). Based on the results of the statistical analysis of these markers, we subsequently genotyped 14 additional markers on the long arm of chromosome 10 (D10S1757, D10S1483, D10S1723, D10S216, D10S575, D10S214, D10S1727, D10S186, D10S1676, D10S1655, D10S1248, D10S1770, D10S1675, D10S590). All these markers were located within a 32-cM interval between markers D10S190 and D10S212. Information on primer sequences was taken from GDB.
One oligonucleotide of each pair of PCR primers was fluorescein labeled. The PCR reaction for each marker was carried out in a 10-l volume containing 40 ng genomic DNA, 5 pmol of each primer, 200 M of each dNTP, 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 1.5-2.5 mM MgCl 2 , and 0.6 U Taq polymerase (Life Technologies, Paisley, UK). After an initial denaturation of 5 min at 95°C, 33 cycles of amplification of 15 s at 94°C, 15 s at 55-62°C, and 30 s at 72°C were performed in a Perkin Elmer 9600 thermocycler. The resulting amplified products were separated on 4.5% denaturing polyacrylamide gels on an automated DNA sequencer (Model 377, Applied Biosystems). Allele sizes were determined relative to an internal size standard in each lane using Genescan Analysis Version 2.1.1 and Genotyper Version 2.0 software (Applied Biosystems). In addition, a reference individual with known genotype was loaded on each gel. All gels were scored independently by two individuals who were blind to the disease status. Each marker was tested for Mendelian inheritance in every family.
Linkage analyses
Two models of affection were used in the linkage analyses: affection status model (ASM) I (narrow definition of the phenotype) included only individuals with BPI as affected, all other psychiatric diagnoses were coded as 'unknown'; ASM II (broad definition) included all individuals with a diagnosis of BPI, BPII SA/BP, and UPR with UPS and other minor psychiatric disorders coded 'unknown'. Two-point LOD scores were calculated by means of MLINK and ILINK programs of the LINKAGE package version 5.2. 58 All analyses were conducted using an 'affecteds-only' approach. For both disease definitions the LOD scores were calculated assuming both a dominant and a recessive mode of inheritance. Under the Molecular Psychiatry broad affection model we assumed a phenocopy rate of 3.2% and a penetrance of 50% under both genetic models. The frequency of the disease allele was set to 24.5% and 3% for the recessive and dominant genetic model, respectively. For the narrow affection model the phenocopy rate was set to 0.1%, penetrance was assumed to be 50% and the frequency of the disease allele was set to 13.4% under recessive and to 0.9% under dominant mode of inheritance. These assumptions correspond to a lifetime morbid risk of 6% for diseases included in ASM II and of 1% for BPI (ASM I). 59 An age-dependency of the penetrance was not taken into account, since using 'affecteds-only' treats unaffected individuals as phenotype unknown, which diminishes the effect of quantifying the correct penetrance.
Multipoint LOD scores as well as non-parametric multipoint analyses were performed using the GENE-HUNTER program Version 2.0B. 60 For the multipoint LOD score analysis, the same models as for the twopoint analysis were used (dominant and recessive mode of inheritance, narrow and broad disease definition). For non-parametric multipoint linkage analysis, identical by descent (IBD) allele sharing among all affected family members (Z-all) was calculated using the score function S all .
The proportion of affected sib pairs sharing alleles identical by descent was calculated using the Genetic Analysis System (GAS). 61 To compensate for disproportionate effects which may be introduced by sibships with more than two affected siblings, any multiple sib-ships were given a strict weighting by 2n. 62 To test for heterogeneity between the families, the admixture test as implemented in the HOMOG program 37 was applied.
